Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crown Castle International Corp (CCI) vs Hims and Hers Health Inc (HIMS) Price & Performance

Crown Castle International CorpTrade
Hims and Hers Health IncTrade

Price performance (Past 24H)

Key statistics

Crown Castle International Corp vs Hims and Hers Health Inc — how do they compare? Crown Castle International Corp trades at $79.21 (market cap $34.50B), while Hims and Hers Health Inc trades at $35.45 (market cap $8.14B). The key difference: Crown Castle International Corp is far larger — about 4.2× Hims and Hers Health Inc's market cap, and Crown Castle International Corp pays a 5.38% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.

CCIHIMS
Market Cap
$34.50B$8.14B
Sector
Real EstateHealth
52-Week High
$113.91$66.18
52-Week Low
$74.92$14.52
Enterprise Value
$64.33B$8.52B
Dividend Yield
5.38%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Crown Castle International Corp

Crown Castle (CCI) trades at $79.84, up 0.23% on the day, with a bearish technical signal from moving averages. The company reported mixed Q1 2026 earnings, missing EPS estimates, but maintains strong profitability with a 73.82% gross margin. Recent news highlights its pure-play U.S. tower focus and upcoming Q2 2026 earnings call on July 22, 2026.

CCI presents a turnaround opportunity with analyst consensus targeting $97.33, implying 22% upside, but faces risks from high debt levels and volatile earnings. The stock's negative equity and bearish technicals warrant caution despite attractive dividend yield and cost reduction initiatives.

Hims and Hers Health Inc

Hims & Hers Health trades at $34.38, showing no change in the last session. The stock exhibits a bullish technical setup with moving averages supporting upward momentum, while oscillators remain neutral. Recent earnings have been mixed, with Q1 2026 missing expectations, but revenue growth remains positive. Analyst sentiment is divided with a 35% buy rating, and the consensus price target is $33.57. News highlights include expansion in weight-loss treatments and a new JPMorgan receivables facility.

The outlook for HIMS is cautiously optimistic, driven by growth in telehealth and weight-loss segments, but high valuation multiples and recent net income declines pose risks. Investment opportunity lies in market expansion and subscriber growth, while execution risks and competitive pressures require monitoring.

Returns comparison

Trailing returns across standard periods

About Crown Castle International Corp

Crown Castle International owns and leases roughly 40,000 cell towers in the United States. It also owns more than 85,000 route miles of fiber. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. The company's fiber is primarily leased by wireless service providers to set up small-cell network infrastructure and by enterprises for their internal connection needs. Crown Castle's towers and fiber are predominantly located in the largest U.S. cities. The company has a very concentrated customer base, with more than 70% of its revenue coming from the big three U.S. mobile carriers. Crown Castle operates as a real estate investment trust.

Read more on CCI

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS